ConductScience.org, home

Trial · NCT00179465

Treating Schizophrenia by Correcting Abnormal Brain Development

NCT00179465, Phase 3, Active not recruiting, Beth Israel Deaconess Medical Center

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Treating Schizophrenia by Correcting Abnormal Brain Development. Trials, record NCT00179465. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00179465

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT number
NCT00179465
Status
Active not recruiting
Phases
Phase 3
Enrollment
36 participants, estimated
Lead sponsor
Beth Israel Deaconess Medical Center
Conditions
Schizophrenia
Interventions
Tiagabine, Placebo
First posted
2005-09-16
Last updated
2025-01-27

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNeurocognitive Functions-Working MemoryWorking memory will be assessed at baseline and at 6-month time point to see if working memory changes after 6 months compared to baseline measurementWorking memory will be assessed using the n-back working memory test
PrimaryNeurocognitive Functions-Executive FunctionExecutive function will be assessed at baseline and at 6-month time point to see if executive function changes after 6 months compared to baseline measureExecutive function, which is a complex form of working memory, will be assessed using the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) battery
SecondaryClinical symptomsSymptoms will be assessed at baseline and at 6-month time point to see if symptoms change after 6 months compared to baseline measuresPositive and negative symptoms will be quantified using PANSS (positive and negative symptom scale)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9560277BACKGROUNDPubMed
15653262BACKGROUNDPubMed
20415633BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
1-Back TaskPrimary outcomeConductCognition
2-Back TaskPrimary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00179465

GET https://conductscience.org/api/trials/v1/NCT00179465/registered